JumpCode Genomics, Inc.
The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.
Funding history
About JumpCode Genomics, Inc.
How much funding has JumpCode Genomics, Inc. raised?
JumpCode Genomics, Inc. has raised $3.5M in total funding. The most recent round was Series B.
Where is JumpCode Genomics, Inc. headquartered?
JumpCode Genomics, Inc. is headquartered in San Diego, CA.
What does JumpCode Genomics, Inc. do?
The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.
What problem does JumpCode Genomics, Inc. solve?
The majority of molecules captured in DNA/RNA sequencing are uninformative, wasting sequencing capacity on unwanted material like ribosomal, mitochondrial, or globin sequences.
What's JumpCode Genomics, Inc.'s solution?
Jumpcode makes programmable endonuclease enzymes (its DepleteX and CRISPRclean product lines) that selectively deplete unwanted RNA/DNA to boost the amount of usable data from NGS and PCR workflows.
What makes JumpCode Genomics, Inc. different?
It offers custom depletion panels targeting anywhere from one to over a million targets, and is launching a new enzyme range in partnership with Revvity.
What makes JumpCode Genomics, Inc. notable?
JumpCode Genomics has raised roughly $38-44M in funding, including a $21M Series B backed by Baird Capital, Arboretum Ventures, and LYZZ Capital.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.